Nektar(NKTR) - 2023 Q4 - Earnings Call Transcript

Howard Robin Operator Thank you. And our next question will come from Roger Song from Jefferies. Your line is open. Kambiz Yazdi Hi, team. This is Kambiz on for Roger. Maybe just following up on the alopecia areata study. How many total clinical sites will you be enrolling and whatÂ's kind of the geographic distribution of those sites? And then, there are some key baseline characteristics for the patients in these studies will be most of them be a JAK inhibitor or refractory. Any detail there would be appre ...